All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
EquityEquity IPOs

Drayson's Sensyne Health trades up 8.6% after IPO on AIM

Lord Drayson PA 230x150

Sensyne Health, the UK healthcare artificial intelligence company, has traded up nicely after the company priced its IPO on London’s alternative investment market (AIM).

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree